Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits

American Journal of Roentgenology

Volumn 197, Issue 4, 2011, Pages

  Hubbard, Rebecca ^a   Kerlikowske, Karla ^b   Buist, Diana ^a   Yankaskas, Bonnie ^c  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CLINICAL EVALUATION; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; HAZARD ASSESSMENT; HUMAN; LETTER; MAMMOGRAPHY; PRIORITY JOURNAL; REPEAT PROCEDURE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STRATEGIC PLANNING; WOMEN'S HEALTH;

ADVISORY COMMITTEES; BREAST NEOPLASMS; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; MAMMOGRAPHY; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC;

EID: 80053231958     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.6791     Document Type: Letter

References (3)

1. Hendrick RE, Helvie MA. United States Preventive Services Task Force Screening Mammography Recommendations: science ignored. AJR 2011; 196:338; [web]W112-W116
2. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:727-737
3. Hubbard RA, Miglioretti DL, Smith RA. Modeling the cumulative risk of a false-positive screening test. Stat Methods Med Res 2010; 19:429-449